These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12091130)

  • 41. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
    Pongtanakul B; Das PK; Charpentier K; Dror Y
    Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Twenty years of severe aplastic anemia treatment at Department of Hematology, University Department of Medicine, Zagreb University Hospital Center, Zagreb, Croatia].
    Mrsić M; Seiwerth RS; Labar B; Bogdanić V; Nemet D; Duraković N; Mikulić M; Sertić D; Aurer I; Radman I; Zupancić-Salek S
    Acta Med Croatica; 2009 Jun; 63(3):209-14. PubMed ID: 19827347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study on the relations between HLA-DRB1 alleles and idiopathic thrombocytopenic purpura in children].
    Wang H; Shen B; Yan W; Hou M; Zhu N; Qi H; Hou H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):290-4. PubMed ID: 12170464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does HLA-DR predict response to specific immunosuppressive therapy in aplastic anaemia?
    Rugman FP; Ashby D; Davies JM
    Br J Haematol; 1990 Apr; 74(4):545-6. PubMed ID: 2346736
    [No Abstract]   [Full Text] [Related]  

  • 46. Therapy of experimental immunologically mediated aplastic anemia in mice by various immunosuppressive and antitumor agents.
    Nemoto K; Hayashi M; Abe F; Takita T; Nakamura T; Takeuchi T; Umezawa H
    Transplant Proc; 1988 Jun; 20(3):545-8. PubMed ID: 3132772
    [No Abstract]   [Full Text] [Related]  

  • 47. Aplastic anemia and immunosuppression.
    Nagy SM; Fisher JJ
    JAMA; 2003 Jul; 290(2):193; author reply 193. PubMed ID: 12851270
    [No Abstract]   [Full Text] [Related]  

  • 48. Immune-mediated aplastic anaemia.
    Corbeel L
    Eur J Pediatr; 2005 Nov; 164(11):698-9. PubMed ID: 15948000
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment strategy of aplastic anemia based on the pathophysiology of individual patients].
    Yamazaki H
    Rinsho Ketsueki; 2011 Oct; 52(10):1507-14. PubMed ID: 21971227
    [No Abstract]   [Full Text] [Related]  

  • 50. Immune complexes in aplastic anaemia.
    Caligaris Cappio F; Novarino A; Camussi G; Gavosto F
    Br J Haematol; 1980 May; 45(1):81-7. PubMed ID: 7378332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunological abnormalities in a child with constitutional aplastic anemia.
    Dohlsten M; Carlsson R; Hedlund G; Sjögren HO; Bekassy AN; Garwicz S
    Pediatr Hematol Oncol; 1986; 3(1):89-96. PubMed ID: 3155254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Efficacy of cyclosporin A in the treatment of aplastic anemia and its mechanism].
    Zhang N; Shao Z
    Zhonghua Xue Ye Xue Za Zhi; 1998 Apr; 19(4):218-20. PubMed ID: 11243137
    [No Abstract]   [Full Text] [Related]  

  • 53. [Thymosin in the treatment of hypo- and aplastic anemia in children].
    Ciepielewska D; Górski A; Nowaczyk M
    Pediatr Pol; 1985 Jan; 60(1):77-81. PubMed ID: 3898002
    [No Abstract]   [Full Text] [Related]  

  • 54. Increased frequency of HLA-DPw3 in severe aplastic anemia (AA).
    Odum N; Platz P; Morling N; Jacobsen N; Jakobsen BK; Ryder LP; Svejgaard A
    Tissue Antigens; 1987 Apr; 29(4):184-5. PubMed ID: 3617032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The human histocompatibility system (HLA) in aplastic anemia (AA) (author's transl)].
    Hurtado Monroy R; Lavalle Montalvo C; Schmill López N; Vega López MA; González Llaven J
    Sangre (Barc); 1980; 25(4):466-70. PubMed ID: 7423338
    [No Abstract]   [Full Text] [Related]  

  • 56. [Diagnosis of immunopathophysiology in bone marrow failure: clinical significance of autoantibody detection].
    Takamatsu H; Nakao S
    Rinsho Ketsueki; 2010 Aug; 51(8):654-63. PubMed ID: 20805672
    [No Abstract]   [Full Text] [Related]  

  • 57. Good outcome with ATG in aplastic anemia: welcome news, though thought-provoking!
    Oberoi S; Bansal D
    Indian Pediatr; 2012 Oct; 49(10):839-40. PubMed ID: 23144107
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunotherapy for childhood aplastic anemia in India: a case for universal healthcare?
    Kanwar VS
    Indian Pediatr; 2012 May; 49(5):354-5. PubMed ID: 22700662
    [No Abstract]   [Full Text] [Related]  

  • 59. [Aplastic anemia].
    Revol Núñez R; Gallo N; González Alvarez F
    Arch Argent Pediatr; 1970 Jul; 68(5):171-6. PubMed ID: 5476702
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of aplastic anemia with anabolic steroids].
    Horzelowa J
    Przegl Lek; 1965; 21(10):607-9. PubMed ID: 5864566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.